Skip to main content
Top

Journal of Nephrology

Issue 2/2014

Content (15 Articles)

Review

Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis

Shou-Liang Hu, Dan Wang, Wen-Jun Gou, Qing-Feng Lei, Te-An Ma, Jun-Zhang Cheng

Review

Nephrolithiasis by Corynebacterium urealyticum infection: literature review and case report

Laura Cappuccino, Paolo Bottino, Adele Torricella, Roberto Pontremoli

Review

Laparoscopic peritoneal dialysis catheter (PDC) insertion: does it really make a difference?

Atul Bagul, Umasankar Mathuram Thiyagarajan, Nizam Mamode

Open Access Original Article

Suppressive effects of iron overloading on vascular calcification in uremic rats

Takuya Seto, Chieko Hamada, Yasuhiko Tomino

Original Article

GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study

Asahi Hishida, Naoyuki Takashima, Tanvir Chowdhury Turin, Sayo Kawai, Kenji Wakai, Nobuyuki Hamajima, Satoyo Hosono, Yuichiro Nishida, Sadao Suzuki, Noriko Nakahata, Haruo Mikami, Keizo Ohnaka, Daisuke Matsui, Sakurako Katsuura-Kamano, Michiaki Kubo, Hideo Tanaka, Yoshikuni Kita

Original Article

Netrin-1, a urinary proximal tubular injury marker, is elevated early in the time course of human diabetes

Calpurnia Jayakumar, Ferdau L. Nauta, Stephan J. L. Bakker, Henk Bilo, Ron T. Gansevoort, Maribeth H. Johnson, Ganesan Ramesh

Original Article

Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement

Yinghua Chen, Hao Bao, Zhengzhao Liu, Haitao Zhang, Caihong Zeng, Zhihong Liu, Weixin Hu

Original Article

Membranoproliferative glomerulonephritis associated with autoimmune diseases

Ladan Zand, Fernando C. Fervenza, Samih H. Nasr, Sanjeev Sethi

Original Article

Abdominal aortic calcification and renal resistive index in patients with chronic kidney disease: is there a connection?

Gabriel Stefan, Cristina Capusa, Simona Stancu, Ligia Petrescu, Elena Dana Nedelcu, Iuliana Andreiana, Gabriel Mircescu

Original Article

Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease

Ismail Kocyigit, Eray Eroglu, Ozcan Orscelik, Aydin Unal, Ozkan Gungor, Fahir Ozturk, Cigdem Karakukcu, Hakan Imamoglu, Murat Hayri Sipahioglu, Bulent Tokgoz, Oktay Oymak

Original Article

The nephrologist’s anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation

Simonetta Genovesi, Emanuela Rossi, Daniela Pogliani, Maurizio Gallieni, Andrea Stella, Fabio Badiali, Ferruccio Conte, Sonia Pasquali, Silvio Bertoli, Patrizia Ondei, Giuseppe Bonforte, Claudio Pozzi, Maria Grazia Valsecchi, Antonio Santoro

Original Article

Geriatric nutritional risk index is a strong predictor of mortality in hemodialysis patients: data from the Riscavid cohort

Vincenzo Panichi, Adamasco Cupisti, Alberto Rosati, Adriana Di Giorgio, Alessia Scatena, Ophelia Menconi, Laura Bozzoli, Anna Bottai

Original Article

Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial

Maryam Pakfetrat, Fatemeh Basiri, Leila Malekmakan, Jamshid Roozbeh

Original Article

A load volume suitable for reaching dialysis adequacy targets in anuric patients on 4-exchange CAPD

Giovambattista Virga, Vincenzo La Milia, Roberto Russo, Luciana Bonfante, Gian Maria Iadarola, Stefano Maffei, Massimo Sandrini, Matthias Zeiler, Maurizio Nordio

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine